AiVF is a rapidly growing medical technology start-up transforming the fertility journey. We are a multidisciplinary team of physicians, embryologists, and computer vision, machine learning, and AI experts leading the next generation of IVF. Advances in fertility treatments have brought millions of children into the world, however, the technology is costly, outdated, and not able to keep up with the soaring demand. Our industry-changing software platform allows optimization of every phase of the fertility process for clinics to increase the certainty of a successful pregnancy for parents-to-be.
AiVF is a medical technology company empowering clinics with Fertility Intelligence™ at anytime, anywhere. Founded and led by world-leading Reproductive Medicine experts, our proprietary AI platform is based on science, backed by research, and driven by real-world clinical use to optimize the fertility journey. EMA™ is a SAAS platform that uses proven artificial intelligence (AI) technology to assist embryo evaluation and support operational efficiencies in IVF clinics. Our AI was trained on the largest, most diverse data sets in collaboration with leading healthcare institutions across the US, Europe, and Asia. Our multidisciplinary team of physicians, embryologists, data scientists, and experts in computer vision, machine learning, and AI are focused on bringing data-driven processes to all phases of the fertility journey.
Total Funding: $25M
Funding Stage: Series A
Business Stage: Scaling Up
Market: B2B2C, B2C, B2B
Company Size: 26 to 50
Founded: 2018
For AI/ML Startup Founders
Get introduced to VC/PE/CVC investors
For Investors at VC/PE firms
Get introduced to AI/ML Startup founders or founders at AiVF
Daniella Gilboa
Co Founder and CEO
Ron Maor
CTO
Amir Sarig
CFO
Amir Lewkowicz
Chief Commercial Officer